{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:19:30Z","timestamp":1775243970796,"version":"3.50.1"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBD) of unknown etiology, characterized by repeated relapse and remission. The efficacy of thiopurine in IBD was first reported in the late 1960s. Thiopurines are used to alleviate the symptoms of IBD, especially UC. These drugs have a steroid-sparing potential and are widely used for the purpose of maintaining long-term remission in steroid-dependent cases. Therefore, thiopurines tend to be used long-term, but adverse events that accompany long-term use, such as lymphoproliferative disorders, must be monitored with care. In contrast, thiopurine plays a critical role in controlling the immunogenicity of biologics. Furthermore, although thiopurine is an old drug, new findings, including the prediction of serious adverse events such as severe alopecia and acute advanced leukopenia, by nudix hydrolase 15 gene polymorphism analysis, as well as the possibility of appropriate drug monitoring by detailed analysis of 6-thioguanine nucleotides have been clarified. However, the consequences of thiopurine withdrawal have not been determined and further studies, including randomized controlled trials, are necessary to answer the clinical question regarding the scenarios in which thiopurine withdrawal is possible.<\/jats:p>","DOI":"10.3389\/fphar.2020.582291","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:18:41Z","timestamp":1611901121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Keiichi","family":"Tominaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimari","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Irisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S774","DOI":"10.1093\/ecco-jcc\/jjaa150","article-title":"Care of the patient with IBD requiring hospitalization during the COVID-19 pandemic","volume":"21","author":"Allez","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00535-015-1142-4","article-title":"NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease","volume":"51","author":"Asada","year":"2016","journal-title":"J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ibd.21844","article-title":"Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort","volume":"18","author":"Ashworth","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2011.406","article-title":"Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up","volume":"305","author":"Bartelds","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cgh.2020.02.009","article-title":"Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases","volume":"18","author":"Beaugerie","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/pds.3621","article-title":"Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies","volume":"23","author":"Beigel","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/s0140-6736(69)90325-0","article-title":"Azathioprine for Crohn's disease","volume":"294","author":"Brooke","year":"1969","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/apt.15458","article-title":"Increased risk of thiopurine-related adverse events in elderly patients with IBD","volume":"50","author":"Calafat","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/ecco-jcc\/jjaa055","article-title":"Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry","volume":"14","author":"Calafat","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/gut.37.5.674","article-title":"A controlled double blind study of azathioprine in the management of Crohn's disease","volume":"37","author":"Candy","year":"1995","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/ajg.2009.410","article-title":"Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal","volume":"104","author":"Cassinotti","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2014.12.011","article-title":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus","volume":"115","author":"Cheng","year":"2015","journal-title":"Antiviral Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/apt.13102","article-title":"Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis","volume":"41","author":"Christophorou","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0091270011435989","article-title":"A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine","volume":"53","author":"Colleoni","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa090449","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/gut.39.3.401","article-title":"6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity","volume":"39","author":"Cuffari","year":"1996","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":"Review article: thiopurines in inflammatory bowel disease","volume":"24","author":"Derijks","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S785","DOI":"10.1093\/ecco-jcc\/jjaa147","article-title":"Best practice guidance for adult infusion centres during the COVID-19 pandemic: report from the COVID-19 international organization for the study of IBD [IOIBD] task force","volume":"21","author":"Dotan","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/s0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/CM9.0000000000000773","article-title":"Salvianolic acid B decreases interleukin-1\u03b2-induced colitis recurrence in mice","volume":"133","author":"Feng","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00535-013-0873-3","article-title":"Hematologic malignancies in the Japanese patients with inflammatory bowel disease","volume":"49","author":"Fukata","year":"2014","journal-title":"J. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/pds.926","article-title":"Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease","volume":"13","author":"Gearry","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","article-title":"Secondary causes of inflammatory bowel diseases","volume":"26","author":"Ghouri","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2036.2009.04023.x","article-title":"Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis","volume":"30","author":"Gisbert","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ajg.2008.88","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"CD010233","DOI":"10.1002\/14651858.CD010233.pub3","article-title":"Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease","volume":"8","author":"Gjuladin-Hellon","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/j.1572-0241.2004.30415.x","article-title":"The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease","volume":"99","author":"Goldenberg","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd european evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","article-title":"Randomised controlled trial of azathioprine withdrawal in ulcerative colitis","volume":"1305","author":"Hawthorne","year":"1992","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00535-003-1139-2","article-title":"Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis","volume":"38","author":"Hibi","year":"2003","journal-title":"J. Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00535-019-01638-x","article-title":"High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype","volume":"55","author":"Kakuta","year":"2020","journal-title":"J. Gastroenterol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00535-017-1416-0","article-title":"Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping","volume":"53","author":"Kakuta","year":"","journal-title":"J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00535-018-1486-7","article-title":"NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study","volume":"53","author":"Kakuta","year":"","journal-title":"J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/tpj.2015.43","article-title":"NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD","volume":"16","author":"Kakuta","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/gutjnl-2020-321244","article-title":"British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic","volume":"69","author":"Kennedy","year":"2020","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/apt.12511","article-title":"A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis","volume":"38","author":"Kennedy","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2017.04.041","article-title":"NUDT15 p.R139C variant is common and strongly associated with azathioprine-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases","volume":"378","author":"Kim","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and ppportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/1346-8138.14588","article-title":"A. Severe thiopurine-induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: retrospective case-control study","volume":"45","author":"Kishibe","year":"2018","journal-title":"J. Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/ijms21051887","article-title":"Altered structural expression and enzymatic activity parameters in quiescent ulcerative colitis: are these potential normalization criteria?","volume":"21","author":"Kj\u00e6rgaard","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.crohns.2008.05.002","article-title":"Lower doses of 6-mercaptopurine\/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients","volume":"2","author":"Komiyama","year":"2008","journal-title":"J Crohns Colitis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/MEG.0000000000000564","article-title":"NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease","volume":"28","author":"Lee","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/tpj.2015.75","article-title":"NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia","volume":"16","author":"Liang","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2036.2009.04027.x","article-title":"Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials","volume":"30","author":"Lichtenstein","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gut.49.5.665","article-title":"Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease","volume":"49","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"B56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ibd\/izx010","article-title":"The addition of an immunosuppressant after loss of response to anti-TNF\u03b1 monotherapy in inflammatory bowel disease: a 2-year study","volume":"18","author":"Macaluso","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.4049\/jimmunol.1302527","article-title":"Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug","volume":"192","author":"Marinkovi\u0107","year":"2014","journal-title":"J. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/ecco-jcc\/jjw152","article-title":"Adalimumab monotherapy and a combination with azathioprine for Crohn's disease: a prospective, randomized trial","volume":"10","author":"Matsumoto","year":"2016","journal-title":"J Crohns Colitis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/MIB.0000000000000400","article-title":"Prognosis of patients with ulcerative colitis in sustained remission after thiopurines withdrawal","volume":"21","author":"Moreno-Rinc\u00f3n","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa193","article-title":"Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review","author":"Muller","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5152\/tjg.2018.17151","article-title":"Efficacy and safety of long-term thiopurine maintenance treatment for ulcerative colitis in Turkey: a single-center experience","volume":"29","author":"\u00d6zgen\u00e7","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","article-title":"Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis","volume":"130","author":"Osterman","year":"2006","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1365-2036.2007.03421.x","article-title":"Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy","volume":"26","author":"Palmieri","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","article-title":"Combination therapy with infliximab and azathioprine is superior to monotherapy with either agentin ulcerative colitis","volume":"46","author":"Panaccione","year":"2014","journal-title":"Gastroenterology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/MIB.0000000000000827","article-title":"Long-term safety and efficacy of low-dose azathioprine and allopurinol cotherapy in inflammatory bowel disease: a large observational study","volume":"22","author":"Pavlidis","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4195968","DOI":"10.1155\/2018\/4195968","article-title":"Sustained clinical efficacy and mucosal healing of thiopurine maintenance treatment in ulcerative colitis: a real-life study","volume":"2018","author":"Pugliese","year":"2018","journal-title":"Gastroenterol Res Pract."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/ibd.21662","article-title":"Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts","volume":"17","author":"Roblin","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.gastro.2020.04.012","article-title":"AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary","volume":"159","author":"Rubin","year":"2020","journal-title":"Gastroenterology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1365-2036.2009.03973.x","article-title":"Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine","volume":"29","author":"Seksik","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/jgh.13494","article-title":"Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients","volume":"32","author":"Shah","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.crohns.2014.01.014","article-title":"Mycophenolate mofetil therapy in the management of inflammatory bowel disease\u2013a retrospective case series and review","volume":"8","author":"Smith","year":"2014","journal-title":"J Crohns Colitis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.14532","article-title":"TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay","volume":"181","author":"Soler","year":"2018","journal-title":"Br. J. Haematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cgh.2006.11.020","article-title":"Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine","volume":"5","author":"Sparrow","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2036.2005.02583.x","article-title":"Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine","volume":"22","author":"Sparrow","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3109\/00365521.2016.1141315","article-title":"Timing for dose-down of 5-ASA depends on mucosal status with ulcerative colitis","volume":"51","author":"Takahashi","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"17751","DOI":"10.1038\/s41598-019-54369-7","article-title":"Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis","volume":"9","author":"Takenaka","year":"2019","journal-title":"Sci. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bjh.13518","article-title":"Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia","volume":"171","author":"Tanaka","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ijc.33213","article-title":"Cancer associates with risk and severe events of COVID-19: a systematic review and meta-analysis","volume":"15","author":"Tian","year":"2021","journal-title":"Int. J. Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B86","doi-asserted-by":"publisher","first-page":"CD000478","DOI":"10.1002\/14651858.CD000478","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","volume":"18","author":"Timmer","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/annrheumdis-2012-202407","article-title":"Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation","volume":"72","author":"van Schouwenburg","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jama.2019.0709","article-title":"Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease","volume":"321","author":"Walker","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ajg.2016.239","article-title":"Higher risk for hematological malignancies in inflammatory bowel disease: a nationwide population-based study in Taiwan","volume":"111","author":"Wang","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","article-title":"Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"B91","doi-asserted-by":"publisher","first-page":"CD007560","DOI":"10.1002\/14651858.CD007560","article-title":"Methotrexate for maintenance of remission in ulcerative colitis","volume":"11","author":"Wang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s12879-020-05371-2","article-title":"Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"104461","DOI":"10.1016\/j.phrs","article-title":"Enhancement of epithelial cell autophagy induced by sinensetin alleviates epithelial barrier dysfunction in colitis","volume":"148","author":"Xiong","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/apt.13796","article-title":"NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease","volume":"44","author":"Zhu","year":"2016","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.582291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:18:43Z","timestamp":1611901123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.582291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":96,"alternative-id":["10.3389\/fphar.2020.582291"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.582291","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"article-number":"582291"}}